Bernstein SocGen Group Upgrades Beam Therapeutics Inc (BEAM) to Outperform

January 7, 2025 7:50 AM EST
Get Alerts BEAM Hot Sheet
Price: $27.53 -3.03%

Rating Summary:
    20 Buy, 7 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 15 | Down: 12 | New: 12
Join SI Premium – FREE

Bernstein SocGen Group analyst William Pickering upgraded Beam Therapeutics Inc (NASDAQ: BEAM) from Market Perform to Outperform with a price target of $37.00 (from $35.00).


For an analyst ratings summary and ratings history on Beam Therapeutics Inc click here. For more ratings news on Beam Therapeutics Inc click here.


Shares of Beam Therapeutics Inc closed at $26.36 yesterday.


You May Also Be Interested In





Related Categories

Analyst PT Change, Upgrades